Protext Mobility

Protext Mobility EPS

Earnings per Share (EPS) of Protext Mobility (TXTM) as of Oct 26, 2026.

EPS

0.00USD

YoY

-1,304.05%

Last updated:

Earnings per Share (EPS) of Protext Mobility is 2025 0.00 USD. Earnings per Share (EPS) of Protext Mobility was 2024 -0.00 USD. It decreases by -1,304.05% higher compared to the previous year.

The Protext Mobility EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2018
-0.00 USD
Jan 1, 2019
-0.00 USD
Jan 1, 2020
-0.00 USD
Jan 1, 2021
-0.00 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
-0.00 USD
Jan 1, 2024
-0.00 USD
Jan 1, 2025
0.00 USD
The Protext Mobility EPS history
YEAREPSYoY
0.00USD-1,304.05%
-0.00USD-21.91%
-0.00USD-109.84%
0.00USD-445.22%
-0.00USD-68.44%
-0.00USD-66.34%
-0.00USD-10.23%
-0.00USD-37.63%
-0.00USD+824.74%
-0.00USD+17.14%
-0.00USD-100.00%
-2.34USD-73.64%
-8.86USD-59.23%
-21.74USD-74.47%
-85.14USD+74.43%
-48.81USD-22.41%
-62.91USD-69.47%
-206.07USD+147.17%
-83.37USD-9.58%
-92.20USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Protext Mobility Stock analysis

What does Protext Mobility do? ProText Mobility, Inc. develops pharmaceutical applications for botanical drugs using proprietary live plant extraction technology. The company focuses on research, testing, and development of highly bioavailable botanical products with all-natural ingredients for nutraceutical and pharmaceutical applications. Its subsidiaries include Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc., which support its product development and market reach. The company generates revenue through the sale of pharmaceutical applications and botanical products developed via its proprietary technology. These products target nutraceutical and pharmaceutical markets, with subsidiaries operating in South Africa and cannabis-related research. The primary buyers are companies in the nutraceutical and pharmaceutical sectors seeking natural, highly bioavailable formulations. Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc. contribute to the company's revenue streams by expanding its product portfolio and market presence. The firm's focus on all-natural ingredients and proprietary extraction methods differentiates its offerings in the nutraceutical and pharmaceutical industries. Protext Mobility is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Protext Mobility stock

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Protext Mobility since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Protext Mobility

All Key Metrics — Protext Mobility